Alpha 2.0
Login Register
» Authors » Pascal Klaus

Pascal Klaus

Explore the profile of Pascal Klaus including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 60
Followers 0
Related Specialties
Rehabilitation Medicine
General Medicine
Science
Top 10 Co-Authors
Thomas Meng
Anja Plenske
Siegfried Wassenberg
Rolf Rau
Peter-Andreas Loschmann
Jacqueline Detert
Thilo Klopsch
Frank Buttgereit
Tanja Braun
Gerd R Burmester
Published In
Rheumatol Ther
PLoS One
Trials
Clin Exp Rheumatol
Acta Derm Venereol
Affiliations
Soon will be listed here.
Recent Articles
1.
Treatment Patterns in Polyarticular Juvenile Idiopathic Arthritis: A Retrospective Observational Health Claims Data Study
Horneff G, Borchert J, Diesing J, Klaus P, Heinrich R, Dally H, et al.
Life (Basel) . 2024 Jun; 14(6). PMID: 38929695
(1) Background: Achieving inactive disease decreases long-term joint damage in patients with polyarticular juvenile idiopathic arthritis (polyJIA). The aim of our study was to describe average time to treatment and...
2.
Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE
Feist E, Baraliakos X, Behrens F, Thaci D, Plenske A, Klaus P, et al.
Rheumatol Ther . 2024 Feb; 11(2):331-348. PMID: 38308727
Introduction: For chronic diseases such as axial spondyloarthritis (axSpA), psoriatic arthritis (PsA), and plaque psoriasis (PsO), treatment goals include remission or at least low disease activity (LDA) by 12 weeks....
3.
Correction: Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA)
Wassenberg S, Rau R, Klopsch T, Plenske A, Jobst J, Klaus P, et al.
Rheumatol Ther . 2023 Nov; 11(1):215. PMID: 38019453
No abstract available.
4.
Correction: Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA)
Wassenberg S, Rau R, Klopsch T, Plenske A, Jobst J, Klaus P, et al.
Rheumatol Ther . 2023 Sep; 11(1):213. PMID: 37728862
No abstract available.
5.
Correction: Effectiveness of Etanercept in Rheumatoid Arthritis: Real-World Data from the German Non-interventional Study ADEQUATE with Focus on Treat-to-Target and Patient-Reported Outcomes
Feist E, Baraliakos X, Behrens F, Thaci D, Klopsch T, Plenske A, et al.
Rheumatol Ther . 2023 Sep; 10(6):1809-1810. PMID: 37668866
No abstract available.
6.
Incidence, prevalence, and comorbidities of juvenile idiopathic arthritis in Germany: a retrospective observational cohort health claims database study
Horneff G, Borchert J, Heinrich R, Kock S, Klaus P, Dally H, et al.
Pediatr Rheumatol Online J . 2022 Nov; 20(1):100. PMID: 36384690
Background: Juvenile idiopathic arthritis (JIA) describes heterogenous categories of chronic inflammatory rheumatic conditions of unknown origin in children and adolescents. Epidemiological data in the literature vary, depending on geographic location,...
7.
Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA)
Wassenberg S, Rau R, Klopsch T, Plenske A, Jobst J, Klaus P, et al.
Rheumatol Ther . 2022 Oct; 10(1):117-133. PMID: 36251174
Introduction: Etanercept (ETN) has been shown to slow radiographic progression of rheumatoid arthritis (RA) and psoriatic arthritis (PsA) in clinical trials. This real-world, non-interventional study assessed radiographic progression in patients...
8.
Effectiveness of Etanercept in Rheumatoid Arthritis: Real-World Data from the German Non-interventional Study ADEQUATE with Focus on Treat-to-Target and Patient-Reported Outcomes
Feist E, Baraliakos X, Behrens F, Thaci D, Klopsch T, Plenske A, et al.
Rheumatol Ther . 2022 Feb; 9(2):621-635. PMID: 35113363
Background: For rheumatoid arthritis (RA), the treat-to-target concept suggests attaining remission or at least low disease activity (LDA) after 12 weeks. Objectives: This German, prospective, multicenter, non-interventional study aimed to...
9.
Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study-a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial
Kedor C, Detert J, Rau R, Wassenberg S, Listing J, Klaus P, et al.
RMD Open . 2021 Jul; 7(2). PMID: 34215704
Objectives: Hand osteoarthritis (OA) is a condition characterised by cartilage degradation and frequently erosive changes. Analgesics and non-steroidal anti-inflammatory drugs are used for symptomatic relief but are often poorly tolerated...
10.
A low-cost, autonomous mobile platform for limnological investigations, supported by high-resolution mesoscale airborne imagery
Barry D, Liardon J, Paccaud P, Klaus P, Gujja Shaik N, Irani Rahaghi A, et al.
PLoS One . 2019 Feb; 14(2):e0210562. PMID: 30763327
Two complementary measurement systems-built upon an autonomous floating craft and a tethered balloon-for lake research and monitoring are presented. The autonomous vehicle was assembled on a catamaran for stability, and...